Nuveen Asset Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.87M | Sell |
299,297
-5,314
| -2% | -$51K | ﹤0.01% | 2232 |
|
|
2024
Q3 | $871K | Sell |
304,611
-98,270
| -24% | -$281K | ﹤0.01% | 2819 |
|
|
2024
Q2 | $1.18M | Buy |
402,881
+130,694
| +48% | +$382K | ﹤0.01% | 2652 |
|
|
2024
Q1 | $868K | Sell |
272,187
-10,444
| -4% | -$33.3K | ﹤0.01% | 2755 |
|
|
2023
Q4 | $950K | Sell |
282,631
-82,560
| -23% | -$277K | ﹤0.01% | 2754 |
|
|
2023
Q3 | $869K | Hold |
365,191
| – | – | ﹤0.01% | 2630 |
|
|
2023
Q2 | $643K | Buy |
+365,191
| New | +$643K | ﹤0.01% | 2839 |
|
|
2022
Q2 | – | Sell |
-98,962
| Closed | -$463K | – | 3437 |
|
|
2022
Q1 | $463K | Buy |
98,962
+1,368
| +1% | +$6.4K | ﹤0.01% | 3040 |
|
|
2021
Q4 | $643K | Sell |
97,594
-10,090
| -9% | -$66.5K | ﹤0.01% | 3002 |
|
|
2021
Q3 | $862K | Buy |
107,684
+8,288
| +8% | +$66.3K | ﹤0.01% | 3043 |
|
|
2021
Q2 | $996K | Buy |
99,396
+491
| +0.5% | +$4.92K | ﹤0.01% | 3007 |
|
|
2021
Q1 | $945K | Buy |
98,905
+65,203
| +193% | +$623K | ﹤0.01% | 2902 |
|
|
2020
Q4 | $370K | Buy |
33,702
+11,274
| +50% | +$124K | ﹤0.01% | 3103 |
|
|
2020
Q3 | $199K | Buy |
+22,428
| New | +$199K | ﹤0.01% | 3161 |
|